Press Release

Pharmaceutical Collaborative Robots Market to Grow with a CAGR of 9.17% through 2028

The quest for superior product quality and the ever-present challenge of skilled labor shortages is expected to drive the Global Pharmaceutical Collaborative Robots Market growth in the forecast period, 2024-2028.

According to TechSci Research report, “Pharmaceutical Collaborative Robots Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Pharmaceutical Collaborative Robots Market stood at USD 64.60 million in 2022 and is anticipated to grow with a CAGR of 9.17% in the forecast period, 2024-2028. This can be attributed to flexibility and scalability. Pharmaceutical manufacturers often face fluctuations in demand. Collaborative robots offer flexibility and scalability, allowing companies to quickly adapt to changing production requirements. This adaptability is particularly advantageous in a market where the need for agile manufacturing is essential.

Furthermore, the integration of the Internet of Things (IoT) in collaborative robots will enable remote monitoring and predictive maintenance. Pharmaceutical manufacturers can track the performance of their cobots in real-time, allowing for proactive maintenance to prevent unexpected downtime and ensure continuous operation.

                                                                                             

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Pharmaceutical Collaborative Robots Market

 

Collaborative robots, often known as cobots, are advanced robotic systems specifically designed for cooperative work with humans within shared workspaces. In contrast to conventional industrial robots that typically operate in isolated environments, cobots come equipped with sensors, safety features, and user-friendly interfaces, enabling safe and efficient interactions with human workers. In the healthcare sector, especially within pharmaceutical settings, cobots are increasingly being deployed for various tasks due to their precision, adaptability, and ability to work alongside human operators. In pharmaceutical laboratories, cobots represent sophisticated robotic systems tailored for seamless and collaborative interaction with human workers. Their adaptability and aptitude for close cooperation with humans have made them increasingly popular in the pharmaceutical industry.

The primary advantage of utilizing cobots in the pharmaceutical sector is their ability to augment human labor, resulting in increased efficiency and productivity in production processes. By integrating cobots into their operations, pharmaceutical companies can accelerate production timelines and boost output while maintaining strict product quality standards. Furthermore, cobots have the potential to enhance worker safety by taking on hazardous and repetitive tasks that might otherwise put human personnel at risk. The global pandemic disrupted supply chains, potentially impacting the availability of pharmaceutical ingredients. Cobots, with their material handling capabilities, played a vital role in sustaining manufacturing and distribution. To comply with safety measures such as social distancing, pharmaceutical companies turned to cobots to ensure worker safety while sustaining operational efficiency.

The heightened demand for medical supplies compelled pharmaceutical companies to employ cobots for rapidly scaling up production to meet urgent healthcare needs. During workforce shortages caused by lockdowns, cobots handled routine tasks, allowing remote human workers to focus on critical production aspects. Cobots' precision in handling and sensing capabilities facilitated COVID-19 research, aiding accurate experimentation and sample handling. The rapid evolution of technology has had a profound impact on various industries, with the pharmaceutical sector being no exception. Adaptability to emerging technologies is crucial in this sector, and cobots exemplify a transformative development that is reshaping pharmaceutical competitiveness and innovation. Cobots have undergone significant enhancements in terms of their capabilities, functionality, and user-friendliness, driven by ongoing research and development efforts.

These advancements, powered by artificial intelligence, machine learning, sensors, and advanced control algorithms, empower cobots to perform intricate tasks with precision. Furthermore, improved user interfaces make automation more accessible, enabling a wider range of employees to effectively optimize processes. Despite the numerous advantages that cobots offer in the pharmaceutical industry, there are several key barriers to their widespread adoption. The initial investment cost can be substantial, including the expenses related to purchasing and integrating cobots, as well as training personnel for their operation. Additionally, cobots must adhere to stringent regulatory standards in the pharmaceutical sector, necessitating comprehensive validation processes and documentation to ensure compliance with safety and quality requirements, which can extend implementation timelines.

The Global Pharmaceutical Collaborative Robots Market is segmented into application, end-use, regional distribution, and company.

Based on its application, the picking and packaging sector asserted its supremacy in the market by securing the largest market share in 2022. This achievement can be attributed to the pivotal role this segment plays in the supply chain and manufacturing processes. Picking and packaging operations are instrumental in efficiently organizing, preparing, and dispatching products. Given the rising demand for streamlined logistics, the rapid growth of e-commerce, and the necessity for precision in delivering products to consumers, companies are giving high priority to automation solutions in these areas.

Consequently, investments in collaborative robots for picking and packaging have witnessed a remarkable surge, strengthening the segment's dominance in the 2022 market. Moreover, this segment is anticipated to experience the swiftest growth with a CAGR during the forecast period. This growth can be attributed to the capability of robots to enhance precision and efficiency while addressing complex material handling challenges. Furthermore, the pick-and-place approach offers these advantages while conserving floor space by operating within a limited work area, effectively optimizing workspace utilization. This trend reflects the industry's commitment to maximizing operational efficiency while ensuring efficient use of available space.

Based on end-use, the pharmaceutical companies sector emerged as the dominant force in the market by securing the largest market share in 2022. This trend can be attributed to the increasing adoption of robotics in drug discovery and development. Additionally, the growth of this segment was fueled by pharmaceutical firms' active involvement in personalized medicine initiatives.

During the projected period, research laboratories are expected to undergo significant expansion, primarily due to the capacity of automation to handle repetitive tasks, such as the transfer of test tubes and fluids, in drug discovery endeavors. This automation enhances precision and consistency in these critical processes.

Moreover, this segment is anticipated to experience the most rapid growth with a CAGR during the forecast period. The industry's steadfast commitment to research and development ensures a continuous stream of improved products, further solidifying its position in the market. Meeting stringent regulatory standards for safety and efficacy also adds to the credibility of pharmaceutical offerings.

Major companies operating in Global Pharmaceutical Collaborative Robots Market are:

  • ABB Limited
  • Universal Robots A/S
  • Mitsubishi Electric Corp
  • KUKA AG
  • Kawasaki Heavy Industries Ltd
  • YASKAWA Electric Corporation
  • Denso Wave Inc
  • Fanuc America Corp

 

Download Free Sample Report

Customers can also request for 10% free customization on this report

 

“The global pharmaceutical collaborative robots market is witnessing a transformative shift as it adapts to the ever-evolving landscape of the pharmaceutical industry. Pharmaceutical manufacturers are embracing the upcoming key trends to address challenges related to efficiency, quality, and flexibility while staying compliant with strict regulations. As technology continues to advance and market demands change, the pharmaceutical collaborative robots market is poised to remain at the forefront of innovation, enabling the industry to meet the increasing global demand for safe and effective pharmaceutical products,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

Global Pharmaceutical Collaborative Robots Market By Application (Picking and Packaging, Inspection of Pharmaceutical Drugs, Laboratory Applications), By End-use (Pharmaceutical Companies, Research Laboratories, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated the future growth potential of Global Pharmaceutical Collaborative Robots Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Pharmaceutical Collaborative Robots Market.


Contact

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +13322586602

Email: [email protected]               

Website: www.techsciresearch.com

Relevant News